Clorox (NYSE:CLX) Price Target Cut to $151.00

Clorox logo with Consumer Staples background

Clorox (NYSE:CLX - Free Report) had its target price lowered by Deutsche Bank Aktiengesellschaft from $155.00 to $151.00 in a report released on Wednesday, Benzinga reports. The firm currently has a hold rating on the stock.

CLX has been the subject of a number of other reports. Morgan Stanley restated an equal weight rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a neutral rating in a report on Thursday, January 18th. UBS Group upped their price target on shares of Clorox from $145.00 to $170.00 and gave the company a neutral rating in a research report on Friday, February 2nd. Barclays reduced their price target on shares of Clorox from $148.00 to $136.00 and set an underweight rating for the company in a research report on Wednesday, April 10th. Finally, The Goldman Sachs Group began coverage on shares of Clorox in a research report on Friday, March 1st. They issued a sell rating and a $140.00 price target for the company. Four equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company's stock. According to MarketBeat.com, Clorox has an average rating of Hold and a consensus target price of $148.63.


Check Out Our Latest Stock Report on CLX

Clorox Price Performance

Shares of Clorox stock traded down $0.19 on Wednesday, hitting $142.29. The company had a trading volume of 839,125 shares, compared to its average volume of 1,209,846. The business has a 50-day simple moving average of $150.67 and a 200-day simple moving average of $141.68. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The company has a market cap of $17.66 billion, a PE ratio of 225.51, a PEG ratio of 2.19 and a beta of 0.43. Clorox has a 52 week low of $114.68 and a 52 week high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm's revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period last year, the firm posted $0.98 earnings per share. Research analysts expect that Clorox will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox's dividend payout ratio is presently 761.92%.

Hedge Funds Weigh In On Clorox

A number of institutional investors have recently modified their holdings of CLX. Tyler Stone Wealth Management acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $25,000. O Dell Group LLC acquired a new position in Clorox during the fourth quarter valued at approximately $28,000. Strategic Investment Solutions Inc. IL acquired a new position in Clorox during the first quarter valued at approximately $31,000. Northwest Financial Advisors bought a new position in Clorox in the fourth quarter valued at approximately $29,000. Finally, GoalVest Advisory LLC bought a new position in Clorox in the first quarter valued at approximately $31,000. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Featured Articles and Offers

Search Headlines: